NRx Pharmaceuticals Inc.
(NRXP)
undefined
undefined%
At close: undefined
1.20
0.00%
After-hours Dec 13, 2024, 04:00 PM EST
Ratios (Annual)
Get detailed income statement breakdowns, uncovering revenue,
expenses, and much more.
Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 |
PE Ratio | -0.29 | -5.18 | -7.82 | -169.31 | 33.01 | 344.30 | -20.82 |
PS Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
PB Ratio | -0.74 | 24.63 | 26.95 | -47.76 | 0.46 | 0.33 | 0.03 |
P/FCF Ratio | -0.40 | -4.59 | -14.87 | -922.16 | -17.01 | -48.10 | -16.10 |
P/OCF Ratio | -0.40 | -4.59 | -14.87 | -922.97 | -17.01 | -48.10 | -16.10 |
OCF/S Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Debt / Equity Ratio | -0.20 | 0.36 | 0.01 | -0.00 | 0.02 | 0.00 | 0.00 |
Quick Ratio | 0.09 | 0.39 | 0.69 | 0.01 | 0.03 | 0.01 | 1.44 |
Current Ratio | 0.09 | 0.39 | 0.69 | 0.02 | 0.03 | 0.01 | 1.44 |
Asset Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Interest Coverage | -57.47 | 0.00 | -1608.28 | -229.41 | 0.00 | 0.00 | 0.00 |
Return on Equity (ROE) | 256.97% | -475.57% | -344.68% | 28.21% | 1.38% | 0.10% | -0.15% |
Return on Assets (ROA) | -412.17% | -136.49% | -219.12% | -419.82% | 1.27% | 0.09% | -0.15% |
Return on Capital (ROIC) | 235.12% | -480.96% | -556.55% | 118.89% | -0.02% | -1.43% | 0.00% |
Dividend Yield | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Payout Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Gross Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Net Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |